Nitya G. Ray's Net Worth
$170 Thousand
Who is Nitya G. Ray?
Nitya G. Ray does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CytoDyn Inc., and Actinium Pharmaceuticals, Inc..
SEC CIK
Nitya G. Ray's CIK is 0001709522
Past Insider Trading and Trends
2022 was Nitya G. Ray's most active year for acquiring shares with 16 total transactions. Nitya G. Ray's most active month to acquire stocks was the month of July. 2019 was Nitya G. Ray's most active year for disposing of shares, totalling 1 transactions. Nitya G. Ray's most active month to dispose stocks was the month of September. 2018 saw Nitya G. Ray paying a total of $68,717.50 for 495,000 shares, this is the most they've acquired in one year. In 2019 Nitya G. Ray cashed out on 187,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CytoDyn Inc. (CYDY) Snapshot price: $0.15945
Chief Technology Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.81% | 13.67K |
—
|
—
| 500.09K |
Nov 15
| |||
Form 4
| +3.42% | 16.08K |
—
|
—
| 486.42K |
Oct 31
| |||
Form 4
| +2.71% | 12.43K |
—
|
—
| 470.33K |
Oct 15
| |||
Form 4
| +2.93% | 13.02K |
—
|
—
| 457.91K |
Sep 30
| |||
Form 4
| +2.06% | 8.96K |
—
|
—
| 444.89K |
Sep 15
| |||
Form 4
| +2.47% | 10.52K |
—
|
—
| 435.92K |
Aug 31
| |||
Form 4
| +1.57% | 6.59K |
—
|
—
| 425.41K |
Aug 15
| |||
Form 4
| +1.72% | 7.1K |
—
|
—
| 418.82K |
Jul 31
| |||
Form 4
| +3.11% | 12.43K |
—
|
—
| 411.72K |
Jul 15
| |||
Form 4
| +3.37% | 13.02K |
—
|
—
| 399.29K |
Jun 30
| |||
Form 4
| +3.67% | 13.67K |
—
|
—
| 386.27K |
Jun 15
| |||
Form 4
| +29.69% | 85.3K |
—
|
—
| 372.6K |
Mar 31 - May 31
| |||
Form 4
| +43.65% | 87.3K |
—
|
—
| 287.3K |
Aug 6
| |||
Form 4
|
∞
| 200K |
—
|
—
| 200K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $5.12
Executive VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
| +100.00% | 10K |
$0.50 | $5,000.00 | 20K |
Mar 6
| |||
Form 4
|
∞
| 10K |
$0.75 | $7,500.00 | 10K |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||